Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Postoperative Ileus Prevention in Spinal Arthrodesis
NCT03852524Phase 2Completed
- Sponsor
- The Ohio State University
- Start
- Feb 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylnaltrexone in postoperative ileus (POI), sponsored by The Ohio State University. Primary endpoint: Time to First Bowel Movement at 30 days. Started Feb 2019; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT03852524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852524.